-
Barriers to condom use: Results for men and women enrolled in HIV risk reduction trials in outpatient drug treatment.
Campbell ANC, Brooks AJ, Pavlicova M, Hu M, Hatch-Maillette MA, Calsyn DA, Tross S. Barriers to condom use: Results for men and women enrolled in HIV risk reduction trials in outpatient drug treatment. Journal of HIV/AIDS & Social Services 2016;15(2):130-146.
-
Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain.
Griffin MJ, McDermott KA, McHugh RK, Fitzmaurice GM, Jamison RN, Weiss RD. Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug and Alcohol Dependence 2016;163(1):216-221.
-
Smoking status and substance use treatment outcomes among Spanish speakers enrolled in substance abuse treatment.
de Dios MA, Cano MA, Childress S, Vaughan E, Cerna Y, Niarua R. Smoking status and substance use treatment outcomes among Spanish speakers enrolled in substance abuse treatment. Journal of Clinical Psychology 2016;72(10):1037-1048.
-
Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder.
Mooney LJ, Hillhouse MP, Thomas C, Ang A, Sharma G, Terry G, Chang L, Walker NR, Trivedi MD, Croteau D, Sparenborg S, Ling W. Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder. Journal of Addiction Medicine 2016;10(4):236-243.
-
Buprenorphine-naloxone plus naltrexone for the treatment of cocaine dependence: The Cocaine Use Reduction with Buprenorphine (CURB) study.
Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas C, Ang A, Matthews AG, Hasson AL, Annon JJ, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest KL, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J. Buprenorphine-naloxone plus naltrexone for the treatment of cocaine dependence: The Cocaine Use Reduction with Buprenorphine (CURB) study. Addiction 2016;111(8):1416-1427.
-
Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.
dela Cruz AM, Carmody T, Greer TL, Rethorst CD, Warden D, Walker NR, Trivedi MH. Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders. American Journal on Addictions 2016;25(3):215-220.
-
Using electronic health record data for substance use screening, brief intervention, and referral to treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.
Wu L, Brady KT, Spratt SE, Dunham AA, Heidenfelder B, Batch BC, Lindblad R, VanVeldhuisen PC, Rusincovitch SA, Killeen TK, Ghitza UE. Using electronic health record data for substance use screening, brief intervention, and referral to treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study. Contemporary Clinical Trials 2016;46:30-37.
-
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
Hser Y, Evans E, Huang D, Weiss RD, Saxon AJ, Carroll KM, Woody GE, Liu DS, Wakim PG, Matthews AG, Hatch-Maillette MA, Jelstrom E, Wiest KL, McLaughlin P, Ling W. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction 2016;111(4):695-705.
-
Interest and preferences for contingency management design among addiction treatment clientele.
Hartzler B, Garrett SB. Interest and preferences for contingency management design among addiction treatment clientele. American Journal of Drug and Alcohol Abuse 2016;42(3):287-295.
-
Decision-making processes as predictors of relapse and subsequent use in stimulant-dependent patients.
Adinoff BH, Carmody T, Walker NR, Donovan DM, Brigham GS, Winhusen TJ. Decision-making processes as predictors of relapse and subsequent use in stimulant-dependent patients. American Journal of Drug and Alcohol Abuse 2016;42(1):88-97.